Chinese Herbal Medicines Might Improve the Long-Term Clinical Outcomes in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: Results of a Decision-Analytic Markov Model

<table class="figure-group"><tr class="fig-image" id="a"><td><object data="https://static.hindawi.com/articles/ecam/volume-2015/639267/figures/639267.fig.003a.svgz" name="639267.fig.003a" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(a) </b>CHMs plus conventional treatment</td></tr><tr class="fig-image" id="b"><td><object data="https://static.hindawi.com/articles/ecam/volume-2015/639267/figures/639267.fig.003b.svgz" name="639267.fig.003b" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(b) </b>Conventional treatment alone</td></tr></table>

<div>Cumulative QALYs over 10-year horizon.</div>

Evidence-Based Complementary and Alternative Medicine

fig3

Figure 3

Figure 3: Chinese Herbal Medicines Might Improve the Long-Term Clinical Outcomes in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: Results of a Decision-Analytic Markov Model 

Figure 3 | Chinese Herbal Medicines Might Improve the Long-Term Clinical Outcomes in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: Results of a Decision-Analytic Markov Model 